Description
Creating new digital standards for disease monitoring using real-world patient data
Ad Scientiam was created in one of the largest research hospitals in Europe (Pitie Salpetriere in Paris) to develop new digital standards around chronic disease monitoring. In collaboration with physicians and patients, we develop software medical devices where patients assess the evolution of their disease themselves. Patients are taking regular tests on their smartphone (cognitive, dexterity, vision…).
With these new and smarter health data, physicians can adapt treatment much faster. It means a transformed care experience for patients, while reducing costs for payers and providers.
Our solution on Multiple Sclerosis, MSCopilot, has received CE marking and is distributed in Europe (U.S. launch under preparation). We have an ambitious R&D pipeline of 10+ solutions (depression, Parkinson’s, rheumatoid arthritis…) and our priority is now to expand in the US, through research and distribution partnerships with pharmaceutical and healthcare organizations.